MktsMarkets

Senti Biosciences Holdings, Inc.
NASDAQ: SNTIKey statistics
SNTI News
Stories mentioning SNTI from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 16.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | ||||||
| Operating Expenses | ||||||||
| Research & Development | 5,281 | 7,760 | 10,516 | 10,029 | 9,281 | 7,771 | 8,655 | 9,151 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 4,632 | 18,658 | 16,948 | 16,798 | 16,397 | 16,167 | 15,215 | 13,356 |
| Operating Income (Loss) | (4,616) | (18,636) | (16,948) | (16,798) | (16,397) | (16,167) | (15,215) | (13,356) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 200.00 | 190.00 | 223.00 | 209.00 | 178.00 | 205.00 | (11.00) | 6.00 |
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income (Loss) | (4,221) | (14,467) | (18,126) | (14,733) | (14,112) | (610.00) | (28,866) | (11,203) |
| Earnings Per Share (Basic) | (0.14) | (0.64) | (0.69) | (0.56) | (1.41) | (0.13) | (6.31) | (2.45) |
| Earnings Per Share (Diluted) | (0.14) | (0.64) | (0.69) | (0.56) | (1.41) | (0.13) | (6.31) | (2.45) |
| Weighted Average Shares Outstanding (Basic) | 30,972 | 22,483 | 26,228 | 26,081 | 10,013 | 4,596 | 4,577 | 4,572 |
| Weighted Average Shares Outstanding (Diluted) | 30,972 | 22,483 | 26,228 | 26,081 | 10,013 | 4,596 | 4,577 | 4,572 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About SNTI
Senti Biosciences Holdings, Inc. (NASDAQ: SNTI) is a stock listed on the Nasdaq Stock Market under the ticker symbol SNTI. It last traded at $0.1700 (Oct 30, 2026, 4:00 PM ET), down 23.9% on the day. That gives Senti Biosciences a market capitalisation of $5.1M.
Over the past 52 weeks SNTI has traded between $0.1600 and $2.88.
Revenue for the quarter ended Mar 31, 2026 was $16.0K; a net loss of $4.2M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $16.0K | -$4.2M | -26381.3% |
| Dec 31, 2025 | — | -$14.5M | — |
| Sep 30, 2025 | — | -$18.1M | — |
| Jun 30, 2025 | — | -$14.7M | — |
From Senti Biosciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…